Global Artificial Intelligence for Drug Discovery Market
Artificial Intelligence for Drug Discovery Market Size And Forecast
According to Verified Market Research, the Global Artificial Intelligence for Drug Discovery Market was valued at USD 175.91 Million in 2018 and is projected to reach USD 2,589.81 Million by 2026, growing at a CAGR of 39.9 % from 2019 to 2026.
Frequently Asked Questions (FAQs)
Global Artificial Intelligence for Drug Discovery Market Outlook
The growing incidences of the rare diseases and in response requirement for the personalized drugs is the major factor contributing to propel the market growth. In addition, AI for drug discovery reduces the cost associated with R&D activities and risks down the failure rate of clinical trials are some other factors that accelerate the market. Moreover, the increasing cross-industry collaboration and partnership led to imposing positive factors on market growth. However, the high cost of AI implementation and limited awareness are factors responsible for hampering the market growth.
Global Artificial Intelligence for Drug Discovery Market Competitive Landscape
The Global Artificial Intelligence for Drug Discovery Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as NVIDIA Corporation, Deep Genomics, IBM Corporation, Cloud Pharmaceuticals, Microsoft, Google, Atomwise, Inc., Insilico Medicine, BenevolentAI, and Exscientia.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.